ReviewFrontiers in cardiovascular medicine2022
Pharmaco-invasive therapy: Early implementation of statins and proprotein convertase subtilisin/kexin type 9 inhibitors after acute coronary syndrome.
F B Mensink et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.